VinFast Reports Wider Q3 Loss Despite Revenue Surge
Vietnamese EV maker VinFast posts $910M Q3 loss as global expansion costs rise, despite 74% jump in vehicle deliveries and strong revenue growth.
NOTRELOAD AI
Oppenheimer Downgrades T-Mobile Amid Slower Growth
Oppenheimer cuts T-Mobile to Perform, citing slowing subscriber growth, intense competition, and pressure on free cash flow after years of strong gains.
Oppenheimer Rates IBM “Outperform” with $360 Target
Oppenheimer initiates coverage of IBM with an Outperform rating, citing strong software growth, consulting recovery, and AI opportunities as key drivers.
Sangamo Moves Forward with Gene Therapy for Fabry Disease
Sangamo Therapeutics receives FDA approval to submit rolling application for ST-920, a one-time gene therapy treating Fabry disease, with accelerated review pathway granted.
Enviri Soars 35% on $3B Clean Earth Sale to Veolia
Enviri stock jumps 35% after announcing $3 billion Clean Earth sale to Veolia and spin-off of Harsco Environmental and Rail businesses into new company.
GSK and AnaptysBio Enter Legal Battle Over Cancer Drug Jemperli
GSK subsidiary Tesaro and AnaptysBio file dueling lawsuits in Delaware court over alleged breaches of their 2014 Jemperli licensing agreement, with trial set for July 2026.